Thermo Fisher Scientific has agreed to acquire Sanofi's sterile fill-finish and packaging facility in Ridgefield, New Jersey. This site will expand Thermo Fisher's pharmaceutical manufacturing capabilities to meet increasing demand from pharmaceutical and biotech clients in the U.S. The transaction, expected to close in the latter half of 2025, involves over 200 employees transferring to Thermo Fisher. The company plans to invest in expanded capacity and enhanced capabilities, strengthening its partnership with Sanofi and regional production infrastructure.